FZD3 and Alzheimer disease: Zhang and colleagues showed that levels of SOX21-AS1 are elevated in the hippocampus of AD mice and that its downregulation may result in increased FZD3/5 expression and activation of Wnt signalling, which offers substantial protection against oxidative stress, reduces neuronal loss, and ultimately improves learning abilities and memory in AD [250].